Methods and compositions for inducing fetal hemoglobin
AssigneeFlagship Pioneering Innovations VI, LLC
InventorsMauricio CORTES, Xiaoji SUN, Anthony Joseph MONTI, Nicholas McCartney PLUGIS
Life of this patent
Estimating the term…
Loading patent…
AssigneeFlagship Pioneering Innovations VI, LLC
InventorsMauricio CORTES, Xiaoji SUN, Anthony Joseph MONTI, Nicholas McCartney PLUGIS
Estimating the term…
The present disclosure provides methods for increasing the quantity and/or the ratios of erythroblasts, reticulocytes, and/or erythrocytes, or progenitors thereof, in which any of these cells express HbF (e.g. HbF+ and/or HbFhigh cells). The present disclosure further provides methods for treating diseases or disorders characterized by, for example, oxygen delivery deficiencies and/or reduced expression and/or activity of hemoglobin. Such diseases, without limitation, are mitigated by therapeutic reactivation of HbF.
-3. (canceled)
A method for directing a change in cell state of a progenitor cell, comprising:
(canceled)
(canceled)
-32. (canceled)
A method for treating a disease or disorder characterized by an abnormal oxygen delivery, comprising:
-47. (canceled)
A method of identifying a candidate perturbation for promoting the transition of a starting population of progenitor cells into erythrocytes comprising HbF or HbF-expressing progenitors thereof, the method comprising:
-64. (canceled)
Dependencies are inferred from the claim text.